Navigation Links
EPA holds seminar on air pollution and cardiovascular disease
Date:5/20/2010

WASHINGTON The U.S. Environmental Protection Agency is sponsoring a seminar called "Breathe Cleaner, Live Longer: Understanding Air Pollution after 40 Years." The event is co-sponsored by the American Heart Association and the U.S. House of Representatives Committee on Science and Technology. World-renowned scientific experts will discuss the impacts of air pollution on life expectancy and cardiovascular disease, and how improvements in air quality have reduced illness.

The seminar is the first in a series that will be held throughout 2010 in Washington, D.C. as part of Air Science 40, a year-long celebration of how EPA's air research has made a difference in air pollution and its impacts on human health.

WHO: Kevin Teichman, Ph.D., deputy assistant administrator of EPA's Office of Research and Development
Rep. Bart Gordon, Chairman, Committee on Science and Technology, U.S. House of Representatives (invited)
Other EPA scientists
University scientists

WHAT: "Breathe Cleaner, Live Longer: Understanding Air Pollution after 40 Years"

WHEN: Friday, May 21, from 12:00 p.m. to 1:30 p.m.

WHERE: Rayburn House Office Building, Room 2325

To register for the seminar, contact Michelle Limes at the American Heart Association at 202-785-7949 or michelle.limes@heart.org.


'/>"/>

Contact: Dave Ryan
ryan.dave@epa.gov
202-564-7827
U.S. Environmental Protection Agency
Source:Eurekalert

Page: 1

Related biology news :

1. New ORNL carbon composite holds promise for bionics
2. Orange corn holds promise for reducing blindness, child death
3. New map of variation in maize genetics holds promise for developing new varieties
4. Energy experts helping Australian households reduce carbon emissions
5. Canadian research breakthrough holds promise for development of effective cancer therapies
6. Nanotechnology holds promise for STD drug delivery
7. New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease
8. High blood sugars impact on immune system holds clues to improving islet cell transplants
9. Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening
10. Research identifies type of vaccine that holds promise in protecting against TB
11. New synthetic form of protein holds promise to stop cancer spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: